Real-World Evidence and Outcomes Associated with Pharmacotherapy in Schizophrenia
- 1 January 2024
- book chapter
- Published by Springer Nature
- p. 1-10
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Research and scholarly methods: Measuring medication adherenceJACCP: Journal of the American College of Clinical Pharmacy, 2023
- Ranking Antipsychotics for Efficacy and Safety in SchizophreniaJAMA Psychiatry, 2020
- Natural History of Schizophrenia2019
- Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation AntipsychoticsJAMA Psychiatry, 2019
- Management of common adverse effects of antipsychotic medicationsWorld Psychiatry, 2018
- Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision makingPharmacoepidemiology and Drug Safety, 2017
- Premature Mortality Among Adults With Schizophrenia in the United StatesJAMA Psychiatry, 2015
- Maintenance Treatment With Long-Acting Injectable AntipsychoticsJAMA, 2014
- Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategiesWorld Psychiatry, 2013
- Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventionsWorld Psychiatry, 2013